Atox Bio
Ness Ziona
About Atox Bio
Atox Bio is a biotechnology company that specializes in infectious diseases, immunomodulators, and critical care.It focuses on novel modulators of the immune response that target key multiple and interrelated pathways of both the adaptive and innate immune response that play critical roles in infectious and inflammatory diseases as well as ischemia/reperfusion injuries. The company was founded in 2003 and headquartered in HaMerkaz, Israel.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $58.4M
- Funding stage: Late Stage Venture
- Last round: Series F (Dec 2017)
- Website: atoxbio.com
- Phone: 97237582807
Industries & Categories
Biotechnology, Clinical Trials, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/atox-bio-105919 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.